Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
Due to the outbreak of the SARS-CoV-2 virus, drug repurposing and Emergency Use Authorization have been proposed to treat the coronavirus disease 2019 (COVID-19) during the pandemic. While the efficiency of the drugs has been discussed, it was identified that certain compounds, such as chloroquine a...
Saved in:
Main Authors: | Seung-Hyun Yoon (Author), Hyun-Lee Lee (Author), Da Un Jeong (Author), Ki Moo Lim (Author), Seong-Jun Park (Author), Ki-Suk Kim (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19
by: Annie Delaunois, et al.
Published: (2021) -
Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study
by: Annie Delaunois, et al.
Published: (2023) -
Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs
by: Sungpil Han, et al.
Published: (2019) -
Proarrhythmic risk assessment of drugs by dVm/dt shapes using the convolutional neural network
by: Da Un Jeong, et al.
Published: (2022) -
Comparative Study on the Clinical Characteristics of Transient Tachypnea of Newborns according to the Need for Invasive Mechanical Ventilation
by: Ho Jun Yoon, et al.
Published: (2023)